
Advanced Therapy in Epilepsy
PMPH-USA Limited (Publisher)
Published on 16. August 2009
Book
Hardback
478 pages
978-1-60795-004-2 (ISBN)
Description
A comprehensive and up-to-date primer on the latest therapeutic advances in the management and treatment of epilepsy. This Includes practical information on diagnostic criteria for all different syndromes along with detailed discussions of appropriate agents.
More details
Language
English
Place of publication
Shelton
United States
Target group
Professional and scholarly
Dimensions
Height: 280 mm
Width: 210 mm
Thickness: 23 mm
Weight
1 gr
ISBN-13
978-1-60795-004-2 (9781607950042)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
James W. Wheless, MDProfessor and Chair of Pediatric NeurologyLeBonheur Chair in Pediatric NeurologyUniversity of Tennessee Health Science CenterMemphis, TennesseeJames Willmore, MDAssociate Dean and Professor of NeurologySaint Louis University School of MedicineSt. Louis, MissouriRoger A. Brumback, MDProfessor of Psychiatry and PathologyChairman, Department of PathologyCreighton University Medical CenterOmaha, Nebraska
Content
Chapter 1: Introduction
Chapter 2: Epilepsy: Brief Historical Perspective
Chapter 3: Definitions and Classification of Epilepsy and Seizures
Chapter 4: Neurophysiologic Basis of Epileptiform Activity
Chapter 5: Epidemiology
Chapter 6: Magnetoencephalography in the Diagnosis and Treatment of Epilepsy
Chapter 7: Clinical Neurophysiology III: Other Techniques
Chapter 8: Neuroimaging in Epilepsy
Chapter 9: Experimental Models of Seizures and Epilepsy
Chapter 10: The EEG of Epilepsy
Chapter 11: Genetic and Chromosomal Disorders in Epilepsy
Chapter 12: Neuropathology of Pediatric Cerebral Resections for Epilepsy
Chapter 13: Neurometabolic Disorders and Epilepsy
Chapter 14: Neurocutaneous Disorders and Epilepsy
Chapter 15: Neonatal Seizures
Chapter 16: Epilepsy in Developmental Disorders
Chapter 17: Epilepsy in Neurodegenerative Diseases
Chapter 18: Acquired Lesions and Epilepsy
Chapter 19: Febrile Seizures
Chapter 20: Convulsive Status Epilepticus
Chapter 21: Clinical Features, Diagnosis, and Treatment of Nonconvulsive Status Epilepticus
Chapter 22: Temporal Lobe Epilepsy Syndromes
Chapter 23: Partial-Onset Seizures and Localization-Related Epilepsy Syndromes
Chapter 24: Generalized Seizures and Generalized Epilepsy Syndromes
Chapter 25: Landau-Kleffner Syndrome and Language Dysfunction in Epilepsy
Chapter 26: Rasmussen Encephalitis
Chapter 27: Nonepileptic Paroxysmal Disorders
Chapter 28: Psychogenic Nonepileptic Seizures
Chapter 29: Neurotransmitters and Drug Development in Epilepsy
Chapter 30: Antiepileptic Drugs: An Overview
Chapter 31: Principles of Pharmacokinetics and Pharmacogenetics of Anticonvulsants
Chapter 32: Pregnancy, Epilepsy, and Drug Treatment
Chapter 33: Epileptic Drug Treatment in Special Populations
Chapter 34: Systemic Metabolic Consequences of Antiepileptic Medication
Chapter 35: Barbiturates
Chapter 36: Benzodiazepines
Chapter 37: Carbamazepine and Oxcarbazepine
Chapter 38: Ethosuximide
Chapter 39: Gabapentin and Pregabalin
Chapter 40: Lamotrigine
Chapter 41: Levetiracetam
Chapter 42: Phenytoin and Fosphenytoin
Chapter 43: Topiramate
Chapter 44: Valproic Acid
Chapter 45: Vigabatrin
Chapter 46: Zonisamide
Chapter 47: Other Antiepileptic Drugs
Chapter 48: Use of Antidepressants in Epilepsy:What All Neurologists Should Know
Chapter 49: Immunotherapy in Epilepsy
Chapter 50: Dietary Therapy for Epilepsy
Chapter 51: Neurostimulation Therapy for Epilepsy
Chapter 52: Epilepsy Surgery
Chapter 53: Prognosis and Ongoing Management of Epilepsy
Chapter 54: Neuropsychiatric Comorbidities with Epilepsy in Children and Adolescents
Chapter 55: Epilepsy and Cognition
Chapter 56: Practical Treatment Strategies of Psychiatric Comorbidities in Adults with Epilepsy
Chapter 57: Therapeutic Uses of Seizures in Neuropsychiatry
Chapter 58: Social Challenges Among Children and Adolescents with Intractable Epilepsy
Chapter 59: Monitoring for Adverse Effects of Antiepileptic Drugs
Chapter 2: Epilepsy: Brief Historical Perspective
Chapter 3: Definitions and Classification of Epilepsy and Seizures
Chapter 4: Neurophysiologic Basis of Epileptiform Activity
Chapter 5: Epidemiology
Chapter 6: Magnetoencephalography in the Diagnosis and Treatment of Epilepsy
Chapter 7: Clinical Neurophysiology III: Other Techniques
Chapter 8: Neuroimaging in Epilepsy
Chapter 9: Experimental Models of Seizures and Epilepsy
Chapter 10: The EEG of Epilepsy
Chapter 11: Genetic and Chromosomal Disorders in Epilepsy
Chapter 12: Neuropathology of Pediatric Cerebral Resections for Epilepsy
Chapter 13: Neurometabolic Disorders and Epilepsy
Chapter 14: Neurocutaneous Disorders and Epilepsy
Chapter 15: Neonatal Seizures
Chapter 16: Epilepsy in Developmental Disorders
Chapter 17: Epilepsy in Neurodegenerative Diseases
Chapter 18: Acquired Lesions and Epilepsy
Chapter 19: Febrile Seizures
Chapter 20: Convulsive Status Epilepticus
Chapter 21: Clinical Features, Diagnosis, and Treatment of Nonconvulsive Status Epilepticus
Chapter 22: Temporal Lobe Epilepsy Syndromes
Chapter 23: Partial-Onset Seizures and Localization-Related Epilepsy Syndromes
Chapter 24: Generalized Seizures and Generalized Epilepsy Syndromes
Chapter 25: Landau-Kleffner Syndrome and Language Dysfunction in Epilepsy
Chapter 26: Rasmussen Encephalitis
Chapter 27: Nonepileptic Paroxysmal Disorders
Chapter 28: Psychogenic Nonepileptic Seizures
Chapter 29: Neurotransmitters and Drug Development in Epilepsy
Chapter 30: Antiepileptic Drugs: An Overview
Chapter 31: Principles of Pharmacokinetics and Pharmacogenetics of Anticonvulsants
Chapter 32: Pregnancy, Epilepsy, and Drug Treatment
Chapter 33: Epileptic Drug Treatment in Special Populations
Chapter 34: Systemic Metabolic Consequences of Antiepileptic Medication
Chapter 35: Barbiturates
Chapter 36: Benzodiazepines
Chapter 37: Carbamazepine and Oxcarbazepine
Chapter 38: Ethosuximide
Chapter 39: Gabapentin and Pregabalin
Chapter 40: Lamotrigine
Chapter 41: Levetiracetam
Chapter 42: Phenytoin and Fosphenytoin
Chapter 43: Topiramate
Chapter 44: Valproic Acid
Chapter 45: Vigabatrin
Chapter 46: Zonisamide
Chapter 47: Other Antiepileptic Drugs
Chapter 48: Use of Antidepressants in Epilepsy:What All Neurologists Should Know
Chapter 49: Immunotherapy in Epilepsy
Chapter 50: Dietary Therapy for Epilepsy
Chapter 51: Neurostimulation Therapy for Epilepsy
Chapter 52: Epilepsy Surgery
Chapter 53: Prognosis and Ongoing Management of Epilepsy
Chapter 54: Neuropsychiatric Comorbidities with Epilepsy in Children and Adolescents
Chapter 55: Epilepsy and Cognition
Chapter 56: Practical Treatment Strategies of Psychiatric Comorbidities in Adults with Epilepsy
Chapter 57: Therapeutic Uses of Seizures in Neuropsychiatry
Chapter 58: Social Challenges Among Children and Adolescents with Intractable Epilepsy
Chapter 59: Monitoring for Adverse Effects of Antiepileptic Drugs